ナトリウレティックペプチド,体量指数,および心不全の臨床結果 軽く減少したまたは保存されたエジェクション分数
John W Ostrominski1, Brendon L Neuen2, Brian L Claggett3
1: Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; : Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Journal of the American College of Cardiology
|September 2, 2025
まとめ
体質指数 (BMI) の上昇は,心臓機能不全 (HF) の患者におけるN- 末端プロB型ナトリウレチンペプチド (NT- proBNP) の低下と関連している. 現在のNT-proBNPの値は,より高いBMIを有する個体におけるリスクを過小評価している可能性があります.
科学分野:
- 心臓病科
- バイオマーカーの研究
- 肥満 医学
背景:
- ナトリウレチンペプチドは,リスクの階層化と臨床試験の適格性を決定する重要な心不全 (HF) バイオマーカーです.
- 現在のHFのガイドラインと試験基準は,BMIのような肥満の測定法を含まないことが多い.
研究 の 目的:
- N-端末型プロB型ナトリウレチンペプチド (NT-proBNP) と,軽く減少または保存されたエジェクション分数 (HFmrEF/HFpEF) のHFにおける臨床結果との関係を調査する.
- 体重指数 (BMI) のカテゴリーに基づいてこの関連を階層化します.
主な方法:
- 4つのグローバル,ランダム化,制御されたHF試験の総合分析.
- 心血管疾患による死亡またはHF入院,心血管疾患による死亡,HF入院,全原因による死亡と評価されたNT-proBNP関連性.
- 連続変数とカテゴリ変数としてのBMIによる分層分析
主要な成果:
- 14, 750人の参加者において,より高いベースラインのBMIは,より低いNT-proBNPレベルと非線形に関連していた.
- 増加したNT-proBNPは独立して心血管疾患の不良結果を予測したが,この関連性はより高いBMI群で鈍化した.
- 同様の絶対リスクでは,BMI ≥35 kg/ m2の個体では,BMI <35 kg/ m2の個体と比較して,NT-proBNP濃度が著しく低かった.
結論:
- 標準的なNT-proBNP値は,より高いBMIを有する患者における有害なHF結果の絶対リスクを過小評価する可能性があります.
- 固定されたNT-proBNPカットオフは,すべてのBMI範囲におけるリスクの階層化に最適ではないかもしれません.
- 高いBMIの集団における正確なリスク評価のために,より低いNT-proBNPの値が必要になる可能性があります.
関連する概念動画
01:29Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
01:28Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80